New painkiller may cut opioid use after scoliosis surgery in teens
NCT ID NCT06471348
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two numbing medicines injected during scoliosis surgery to see which one better controls pain and reduces the need for strong opioid painkillers. About 128 teens aged 10 to 17 will be randomly assigned to receive either a long-acting numbing drug (liposomal bupivacaine) or a standard numbing drug (bupivacaine with epinephrine). The goal is to improve recovery and lower opioid use after spinal fusion.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADOLESCENT IDIOPATHIC SCOLIOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Boston Children's Hospital
RECRUITINGBoston, Massachusetts, 02115, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can cold therapy and special rinses tame tooth pain after pulpotomy?
- Could an extra spinal cut straighten scoliosis better?
- Could a playlist be the new Post-Surgery comfort?
- Can a new nerve block ease pain after lung surgery?
- Can scoliosis weaken more than the spine? a study investigates
- A shot that might dull post-surgery pain and cut opioid use in teens